Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody ...

KalVista has licenced the commercialisation rights for sebetralstat, a hereditary angioedema (HAE) treatment, to Kaken in ...

The UK Government has announced a £600m ($764m) funding pot to create a new Health Data Research Service, reducing red tape ...

Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, and Eli Lilly’s Kisunla (donanemab) in July ...

US President Donald Trump told reporters last week that pharma tariffs are coming “sometime in the near future”.

The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag International’s Darzalex ...

US policy changes to withdraw from the WHO and cut USAID have had clinical repercussions throughout Africa. We explore the ...

Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory ...